Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in

Podcasts

Episode 18: The fight for children's eyesight

What can we do to reduce mounting myopia prevalence?

Global prevalence of myopia in children and adolescents is set to reach 40% by 2050, exceeding 740 million cases.

Reducing incidence and slowing progression is essential, as myopia is linked to sight-threatening complications like retinal detachment, myopic macular degeneration, and glaucoma. Dr. Annegret Dahlmann-Noor explores the reasons behind this increase and what we can do to halt the trend.

Listen now

Stay up to date with our podcasts

Medicine Matters keeps practicing doctors informed of key clinical developments, discusses controversial issues in medicine, and helps doctors be sure that their patient care is up to date.

Register today

More episodes from Medicine Matters

Episode 0: Introducing Medicine Matters

In this episode, Dr. Jane Godsland & Dr. Erik Heintz introduce the new platform and podcast. 

» Listen now

Episode 1: From Gray's to Google

We talk to Dr. Nathalie van Havre and Dr. Elsbeth Headley about ongoing medical education in the digital age. 

» Listen now

Episode 2: Progress in PARP inhibitors

In this episode, Dr. Elena Castro takes us through the latest evidence for PARP inhibitors and their combinations in this setting.

» Listen now

Episode 3: Unravelling resistant hypertension

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options. 

» Listen now

Episode 4: Stem cell therapy for PD

Prof. Malin Parmar explains why stem cell therapy is such a good option for patients with Parkinson’s disease and how its safety is being tested in the STEM-PD trial.

» Listen now

Episode 5: Next-generation sequencing in cancer

Professor Andrew Beggs discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers

Supported by: Illumina, Inc., and Eli Lilly and Company

» Listen now

Episode 6: OCT for coronary imaging

Drs Niels Holm and Lene Andreasen bring us up to speed with the latest evidence, and explore whether we should expect to see this technology in use in our clinics in the future.

» Listen now

Episode 7: A deep dive into ADAURA

A conversation with Dr. Luis Paz-Ares about the key questions raised by the ADAURA trial of adjuvant osimertinib in early-stage NSCLC.

» Listen now

Episode 8: AI in stroke

Prof. Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists in predicting patients’ clinical outcomes after stroke.

» Listen now

Episode 9: The gut microbiome and CAR T-cell therapy

Prof. Marion Subklewe explores the interplay between the gut microbiota and the efficacy and safety of CAR T-cell therapy in people with hematologic malignancies.

» Listen now

Episode 10: Disease-modifying therapy for type 1 diabetes

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape. 

» Listen now

Episode 11: Cardiac rehabilitation in patients with frailty

Dr. Eduard Shantsila discusses rehabilitation approaches for complex patients with heart disease and comorbid frailty, including those with cognitive vulnerability.

» Listen now

Episode 12: Defining ARDS

Since publication of the Berlin criteria for ARDS in 2012, several developments have prompted the need for an update. Last year, an international group of experts rose to the challenge. But is the new definition necessary and will it have an impact on clinical practice? Prof. Giacomo Grasselli shares his thoughts.

» Listen now

Episode 13: Advances in MASLD and MASH

Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.

» Listen now

Episode 14: Diagnostic criteria for AD

Dr. Nicolas Villain outlines why it is so important to consider both clinical symptoms and biological findings when diagnosing Alzheimer's disease. 

» Listen now

Episode 15: Breastfeeding after breast cancer

We talk to Dr. Cristina Saura about the concerns around breastfeeding after a breast cancer diagnosis, and why the POSITIVE results are such good news.

» Listen now

Episode 16: Sexual health in older age

Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.

» Listen now

Episode 17: Challenges of developing DMOADs

Prof. Ali Mobasheri identifies the key issues in developing a successful disease-modifying osteoarthritis drug and how they can be overcome.

Subscribe to Medicine Matters via...

Adis Journal Podcasts

Podcast

Navigating the treatment of renal cell carcinoma: Insights on the current treatment landscape and managing patient health

In recent years, tremendous efforts have been made in the medical treatment of metastatic renal cell carcinoma (mRCC), with immune-oncological combinations standing as the current standard of care in the first-line setting of mRCC. In these podcasts, expert authors discuss the current treatment landscape for these new therapies and discuss what should be taken into account when choosing the most appropriate treatment for their patients so as to balance outcomes, adverse events and quality of life.

Supported by:
  • Eisai Europe Limited
Listen now
Podcast

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Listen now
Image Credits